1、Table of Contents Table of Contents As filed with the Securities and Exchange Commission on March 10,2004 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K (MARK ONE)or Commission File No.1-3305 Merck&Co.,Inc.One Merck Drive Whitehouse Station,N.J.08889-0100 (908)423-10
2、00 Securities Registered pursuant to Section 12(b)of the Act:Number of shares of Common Stock($0.01 par value)outstanding as of February 27,2004:2,224,326,514.Aggregate market value of Common Stock($0.01 par value)held by non-affiliates on June 30,2003 based on closing price on June 30,2003:$135,610
3、,000,000.Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to
4、such filing requirements for the past 90 days.Yes X No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein,and will not be contained,to the best of registrants knowledge,in definitive proxy or information statements incorporated by
5、 reference in Part III of this Form 10-K or any amendment to this Form 10-K.Indicate by check mark whether the registrant is an accelerated filer(as defined in Exchange Act Rule 12b-2).Yes X No Documents Incorporated by Reference:X Annual Report Pursuant to Section 13 or 15(d)of the Securities Excha
6、nge Act of 1934 For the Fiscal Year Ended December 31,2003 Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934 For the transition period from to Incorporated in New Jersey I.R.S.Employer Identification No.22-1109110 Title of Each Class Name of Each Exchange on whi